Related references
Note: Only part of the references are listed.Glutamine Deprivation Induces PD-L1 Expression via Activation of EGFR/ERK/c-Jun Signaling in Renal Cancer
Guofeng Ma et al.
MOLECULAR CANCER RESEARCH (2020)
CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC
Jeffrey H. Becker et al.
CANCER RESEARCH (2019)
Enhanced Glycolysis Supports Cell Survival in EGFR-Mutant Lung Adenocarcinoma by Inhibiting Autophagy-Mediated EGFR Degradation
Ji Hye Kim et al.
CANCER RESEARCH (2018)
NRF2 facilitates breast cancer cell growth via HIF1α-mediated metabolic reprogramming
Hong-Sheng Zhang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast Cancer
Takahiro Maeda et al.
CANCER RESEARCH (2018)
The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer
Nan Zhang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Modulation of Macrophage Inflammatory Nuclear Factor κB (NF-κB) Signaling by Intracellular Cryptococcus neoformans
James B. Hayes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Systematic investigation of metabolic reprogramming in different cancers based on tissue-specific metabolic models
Fangzhou Shen et al.
JOURNAL OF BIOINFORMATICS AND COMPUTATIONAL BIOLOGY (2016)
Cancer statistics for Hispanics/Latinos, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
Jin Peng et al.
CANCER RESEARCH (2015)
Classifying Cancers Based on T-cell Infiltration and PD-L1
Michele W. L. Teng et al.
CANCER RESEARCH (2015)
PD-L1 expression as a potential predictive biomarker
Alberto Fusi et al.
LANCET ONCOLOGY (2015)
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Christina Twyman-Saint Victor et al.
NATURE (2015)
HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients
Shamaila Munir et al.
CANCER RESEARCH (2013)
The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
Xiaofeng Jiang et al.
CLINICAL CANCER RESEARCH (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
Increase in claudin-2 expression by an EGFR/MEK/ERK/c-Fos pathway in lung adenocarcinoma A549 cells
Akira Ikari et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Enhanced EGFR activity of prostate cancer cells by low pH, low glucose environment
Lakshmi R. Bollu et al.
CANCER RESEARCH (2011)
PD-1/PD-L1 Interactions Contribute to Functional T-Cell Impairment in Patients Who Relapse with Cancer After Allogeneic Stem Cell Transplantation
Wieger J. Norde et al.
CANCER RESEARCH (2011)
Lactate: A Metabolic Key Player in Cancer
Franziska Hirschhaeuser et al.
CANCER RESEARCH (2011)
Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action
Yongtao Jiang et al.
CYTOTECHNOLOGY (2010)
Hypoxic Tumor Microenvironment and Cancer Cell Differentiation
Yuri Kim et al.
CURRENT MOLECULAR MEDICINE (2009)
Mechanisms of tumor resistance to EGFR-targeted therapies
Elizabeth A. Hopper-Borge et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
HIF-1 mediates the Warburg effect in clear cell renal carcinoma
Gregg L. Semenza
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2007)
Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: A mechanism of tumor evasion
AH Zea et al.
CANCER RESEARCH (2005)
Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small-cell lung cancer (NSCLC)
T Mukohara et al.
LUNG CANCER (2003)
Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene -: Its possible role in the Warburg effect
A Minchenko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Inhibition of tumor cell growth by a specific 6-phosphofructo-2-kinase inhibitor, N-bromoacetylethanolamine phosphate, and its analogues
T Hirata et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2000)
Cells overexpressing fructose-2,6-bisphosphatase showed enhanced pentose phosphate pathway flux and resistance to oxidative stress
J Boada et al.
FEBS LETTERS (2000)
Share Paper
